Renee Perry
About Renee Perry
Renee Perry serves as the Senior Manager of Clinical Data Management at Aimmune Therapeutics in Brisbane, CA, a position she has held since 2017. Her previous experience includes roles at St. Jude Medical, Genentech, PAREXEL, and Arena Pharmaceuticals.
Work at Aimmune Therapeutics
Renee Perry has served as the Senior Manager of Clinical Data Management (CDM) at Aimmune Therapeutics since 2017. In this role, she is responsible for overseeing clinical data management processes and ensuring the integrity of clinical trial data. Her tenure at Aimmune Therapeutics has spanned seven years, during which she has contributed to the company's mission of developing treatments for food allergies. The organization is based in Brisbane, California.
Previous Experience in Clinical Data Management
Prior to her current position, Renee Perry held several roles in clinical data management. She worked at St. Jude Medical as a Clinical Data Analyst from 2006 to 2008. Following that, she served as a Clinical Data Manager at Genentech from 2008 to 2012. Additionally, she worked at PAREXEL in a similar capacity from 2001 to 2004. These positions provided her with extensive experience in managing clinical data and supporting clinical trials.
Educational Background in Physics
Renee Perry earned her Bachelor of Arts degree in Physics from the University of California, San Diego. She attended the university from 2002 to 2005, where she developed a strong foundation in scientific principles and analytical skills. This educational background has likely contributed to her expertise in clinical data management and analysis.
Early Career in Research and Data Management
Renee Perry began her career as a Research Associate at Arena Pharmaceuticals, where she worked from 2005 to 2006. Following this role, she transitioned to clinical data management, starting at PAREXEL. Her early career experiences laid the groundwork for her subsequent roles in clinical data analysis and management, ultimately leading to her current position at Aimmune Therapeutics.